The present invention generally relates to diseases or conditions modulated by undesired protein expression. In one aspect, the methods provide for administration to a mammal, particularly a human, of a therapeutically effective amount of a carbocyclic aryl compound capable of modulating that undesired protein expression. Assays for detecting compounds having desired therapeutic capacity are also provided.

 
Web www.patentalert.com

< Pyrimidinecarboxamide derivatives

> Neuregulin-1 transgenic mouse and methods of use

> Compositions useful as inhibitors of protein kinases

~ 00531